A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line

Immunology

Volumn 110, Issue 2, 2003, Pages 206-216

  Vega, Mario I ^a,b   Santos Argumedo, Leopoldo ^b   Huerta Yepez, Sara ^a,b   Luría Perez, Rosendo ^a,b   Ortiz Navarrete, Vianney ^b   Isibasi, Armado ^c   González Bonilla, Cesar R ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; B7 ANTIGEN; BACTERIAL PROTEIN; CD23 ANTIGEN; CD40 LIGAND; GLYCOPROTEIN GP 39; HYBRID PROTEIN; OUTER MEMBRANE PROTEIN C; RECOMBINANT ANTIGEN; SERINE; TRYPSIN; TRYPTOPHYLALANYLGLUTAMYLLYSYLGLYCYLTYROSYLTYROSYLTHREONYLMETHIONYLSERINE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CHIMERA; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE CONSTRUCT; HISTOCOMPATIBILITY COMPLEX; LYMPHOMA CELL LINE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAJI CELL; SALMONELLA TYPHI; SEROTYPE; SOLUBILIZATION;

AMINO ACID SEQUENCE; ANTIGENS, CD40; BURKITT LYMPHOMA; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PORINS; RECOMBINANT FUSION PROTEINS; SALMONELLA TYPHI; TUMOR CELLS, CULTURED;

EID: 0141888352     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01717.x     Document Type: Article

References (47)

1. Armitage RJ, Fanslow WC, Strockbine L et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357:80-2.
2. + T cells. J Immunol 1993; 151:2497-510.
3. Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 1992; 22:2573-8.
4. Carbone E, Ruggiero G, Terrazzano G et al. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J Exp Med 1997; 185:2053-60.
5. Gauchat JF, Henchoz S, Mazzei G et al. Thompson. J. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365:340-3.
6. Gauchat JF, Henchoz S, Fattah D et al. CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 1995; 25:863-5.
7. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995; 378:617-20.
8. Kamanaka M, Yu P, Yasui T et al. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996; 4:275-81.
9. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16:111-35.
10. Armitage RJ, Maliszewski CR, Alderson MR, Grabstein KH, Spriggs MK, Fanslow WC. CD40L: a multi-functional ligand. Semin Immunol 1993; 5:401-12.
11. Hollenbaugh D, Ochs HD, Noelle RJ, Ledbetter JA, Aruffo A. The role of CD40 and its ligand in the regulation of the immune response. Immunol Rev 1994; 138:23-37.
12. Allen RC, Armitage RJ, Conley ME et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259:990-3.
13. Aruffo A, Farrington M, Hollenbaugh D et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72:291-300.
14. DiSanto JP., Bonnefoy JY, Gauchat JF, Fischer A, de Saint BG. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 1993; 361:541-3.
15. Callard RE, Armitage RJ, Fanslow WC, Spriggs MK. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 1993; 14:559-64.
16. Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Noelle RJ. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 1994; 180:157-63.
17. Grewal IS, Flavell RA. The CD40 ligand. At the center of the immune universe? Immunol Res 1997; 16:59-70.
18. Karpusas M, Hsu YM, Wang JH, Thompson J, Lederman S, Chess L, Thomas D. 2A crystal structure of an extracellular fragment of human CD40 ligand. Structure 1995; 3:1031-9.
19. Bajorath J, Chalupny NJ, Marken JS et al. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction. Biochemistry 1995; 34:1833-44.
20. Banner DW, D'Arcy A, Janes W et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 1993; 73:431-45.
21. Bajorath J, Aruffo A. Construction and analysis of a detailed three-dimensional model of the ligand binding domain of the human B cell receptor CD40. Proteins 1997; 27:59-70.
22. Bajorath J, Marken JS, Chalupny NJ et al. Analysis of gp39/CD40 interactions using molecular models and site- directed mutagenesis. Biochemistry 1995; 34:9884-92.
23. Durandy A, Schiff C, Bonnefoy JY et al. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome. Eur J Immunol 1993; 23:2294-9.
24. Mazzei GJ, Edgerton MD, Losberger C et al. Recombinant soluble trimeric CD40 ligand is biologically active. J Biol Chem 1995; 270:7025-8.
25. Hsu YM, Lucci J, Su L, Ehrenfels B, Garber E, Thomas D. Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes. J Biol Chem 1997; 272: 911-5.
26. Grassme H, Bock J, Kun J, Gulbins E. Clustering of CD40 ligand is required to form a functional contact with CD40. J Biol Chem 2002; 277:30289-99.
27. Ferrant JL, Wilson CA, Benjamin CD et al. Variation in the ordered structure of complexes between CD154 and anti- CD154 monoclonal antibodies. Mol Immunol 2002; 39:77-84.
28. Puente JL, Juarez D, Bobadilla M, Arias CF, Calva E. The Salmonella ompC gene: structure and use as a carrier for heterologous sequences. Gene 1995; 156:1-9.
29. Skurray RA, Hancock RE, Reeves P. Con- mutants: class of mutants in Escherichia coli K-12 lacking a major cell wall protein and defective in conjugation and adsorption of a bacteriophage. J Bacteriol 1974; 119:726-35.
30. Cole ST, Sonntag I, Henning U. Cloning and expression in Escherichia coli K-12 of the genes for major outer membrane protein OmpA from Shigella dysenteriae, Enterobacter aerogenes, and Serratia marcescens. J Bacteriol 1982; 149:145-50.
31. Blanco LP, Toro CS, Romero JM, Santiviago CA, Mora GC. Salmonella typhi Ty2 OmpC porin induces bactericidal activity on. U937 Monocytes Microbiol Immunol 1997; 41:999-1003.
32. Aguero J, Mora G, Mroczenski-Wildey MJ, Fernandez-Beros ME, Aron L, Cabello FC. Cloning, expression and characterization of the 36 KDa1 Salmonella typhi porin gene in Escherichia coli. Microb Pathog 1987; 3:399-407.
33. Paniagua J, Martin N, Ortiz V, Ramirez G, Gonzalez CR, Isibasi A. Predicted epitopes of Salmonella typhi OmpC porin are exposed on the bacterial surface. Immunol Infect Dis 1995; 5:244-9.
34. Arockiasamy A, Krishnaswamy S. Purification of integral outer-membrane protein OmpC, a surface antigen from Salmonella typhi for structure-function studies: a method applicable to enterobacterial major outer-membrane protein. Anal Biochem 2000; 283:64-70.
35. Erdei J, Forsgren A, Naidu AS. Lactoferrin binds to porins OmpF and OmpC in Escherichia coli. Infect Immun 1994; 62:1236-40.
36. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
37. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
38. Towbin H, Staehelin T, Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
39. Epstein MA, Achong BG, Barr YM, Zajac B, Henle G, Henle W. Morphological and virological investigations on cultured Burkitt tumorlymphoblasts(strainRaji). J Natl Cancer Inst 1966; 37:547-59.
40. Goding JW. Conjugation of antibodies with fluorochromes: modifications to the standard methods. J Immunol Methods 1976; 13:215-26.
41. Ranheim EA. Kipps TJ. Activated T cells induce expression of B7/ BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 1993; 177:925-35.
42. Yepez SH, Pando RH, Argumedo LS et al. Therapeutic efficacy of an E. coli strain carrying and ovalbumin allergenic peptide as a fused protein to OmpC in a murine model of allergic airway inflammation. Vaccine 2003; 21:566-78.
43. Ellmark P, Ottosson C, Borrebaeck CA, Malmborg Hager AC, Furebring C. Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-CoDeR phage display library. Immunology 2002; 106:456-63.
44. Jeannin P, Renno T, Goetsch L et al. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat Immunol 2000; 1:502-9.
45. Galdiero M, Vitiello M. Sanzari E, D'Isanto M, Tortora A, Longanella A, Galdiero S. Porins from Salmonella enterica serovar Typhimurium activate the transcription factors activating protein 1 and NF-kappaB through the Raf-1-mitogen-activated protein kinase cascade. Infect Immun 2002; 70:558-68.
46. Gupta S, Kumar D, Vohra H, Ganguly NK. Involvement of signal transduction pathways in Salmonella typhimurium porin activated gut macrophages. Mol Cell Biochem 1999; 194:235-43.
47. Muller A, Gunther D, Dux F, Naumann M, Meyer TF, Rudel T. Neisserial porin (PorB) causes rapid calcium influx in target cells and induces apoptosis by the activation of cysteine proteases. EMBO J 1999; 18:339-52.